Roche Holding AG ROG-CH:Swiss Exchange

*Data is delayed | CHF
Last | 04/09/21 CEST
309.65quote price arrow up+2.50 (+0.81%)
Volume
1,022,073
52 week range
290.55 - 357.85

...

Loading . . .
  • Open307.15
  • Day High309.65
  • Day Low305.35
  • Prev Close307.15
  • 52 Week High357.85
  • 52 Week High Date04/28/20
  • 52 Week Low290.55
  • 52 Week Low Date10/30/20

Key Stats

  • Market Cap284,973.86M
  • Shares Out853.13M
  • 10 Day Average Volume1.3M
  • Dividend9.10
  • Dividend Yield2.94%
  • Beta0.08
  • YTD % Change0.21

KEY STATS

  • Open307.15
  • Day High309.65
  • Day Low305.35
  • Prev Close307.15
  • 52 Week High357.85
  • 52 Week High Date04/28/20
  • 52 Week Low290.55
  • 52 Week Low Date10/30/20
  • Market Cap284,973.86M
  • Shares Out853.13M
  • 10 Day Average Volume1.3M
  • Dividend9.10
  • Dividend Yield2.94%
  • Beta0.08
  • YTD % Change0.21

RATIOS/PROFITABILITY

  • EPS (TTM)16.52
  • P/E (TTM)18.74
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest From Roche Holding AG

There is no recent news for this security.

Profile

MORE
Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including...
Christoph Franz
Non-Executive Chairman
Alan Hippe
Chief Financial Officer
Claudia Boeckstiegel
General Counsel
Address
Grenzacherstr. 124
Basel
4058
Switzerland